Viewing Study NCT04980833


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-31 @ 1:05 AM
Study NCT ID: NCT04980833
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-09
First Post: 2021-07-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Assessing Long-term Safety and Efficacy of Alpelisib in Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Who Previously Participated in Study CBYL719F12002 (EPIK-P1)
Sponsor: Novartis Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module